Nuwellis (NUWE) Net Margin (2013 - 2026)
Nuwellis' (NUWE) quarterly Net Margin came in at 245.15% in Q2 2026, up 48250.0% on a YoY basis from N/an in Q2 2025, and down 29.79% quarter-over-quarter from 188.89% in Q1 2026.
Powered by 
Analysis
Nuwellis (NUWE) Net Margin (2013 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported Net Margin for 14 consecutive years, with 245.15% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Margin rose 48250.0% year-over-year to 245.15%; the trailing twelve-month figure through Jun 2026 stood at 125.57% (up 5085.0% YoY), and the FY2025 full-year result was 211.81%, down 9026.0% from the prior year.
- Net Margin fell to 245.15% in Q2 2026 per NUWE's latest filing, from 188.89% in the prior quarter.
- Across five years, Net Margin topped out at 99.62% in Q3 2024 and bottomed at 727.65% in Q2 2025.
- Historically, Net Margin has averaged 195.7% across 5 years, with a median of 191.28% in 2022.
- The sharpest annual moves came in 2025 and 2026: Net Margin plunged 37556 bps in 2025, then soared 48250 bps in 2026.
- Over 5 years, Net Margin stood at 48.14% in 2022, then slumped by 745 bps to 310.74% in 2023, then surged by 80 bps to 63.22% in 2024, then plunged by 58 bps to 99.88% in 2025, then sank by 145 bps to 245.15% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 245.15%, 188.89%, and 99.88% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 7.37% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 28.46% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 15.17% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 19.37% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 16.67% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 13.87% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 19.04% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 13.47% |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | -245.15% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -245.15% |
| Mar 31, 2026 | -188.89% |
| Dec 31, 2025 | -99.88% |
| Sep 30, 2025 | 21.15% |
| Jun 30, 2025 | -727.65% |
| Mar 31, 2025 | -158.25% |
| Dec 31, 2024 | -63.22% |
| Sep 30, 2024 | 99.62% |
| Jun 30, 2024 | -352.10% |
| Mar 31, 2024 | -204.04% |
| Dec 31, 2023 | -310.74% |
| Sep 30, 2023 | -139.72% |
| Jun 30, 2023 | -233.49% |
| Mar 31, 2023 | -355.15% |
| Dec 31, 2022 | 48.14% |
| Sep 30, 2022 | -187.41% |
| Jun 30, 2022 | -193.67% |
| Mar 31, 2022 | -232.24% |
| Dec 31, 2021 | -15.16% |
| Sep 30, 2021 | -284.51% |